A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis

Name: A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Creator: Vivli
Published: 2025-10-02 17:05:34
License: 暂无描述

DataCite Commons2025-10-02 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00007576/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The main purpose of this study is to evaluate the efficacy and safety of ixekizumab in tumor necrosis factor (TNF) inhibitor-experienced participants with radiographic axial spondyloarthritis (rad-axSpA).

提供机构：

Vivli

创建时间：

2021-12-23